Analysis of Nuclear Receptor Coactivator 5 (NCOA5) Messenger RNA Expression and rs2903908 Single Nucleotide Polymorphism of NCOA5 in an Egyptian Cohort with Behçet’s Disease: A Single-Center Case-control Study

References

• Mazzoccoli G, Matarangolo A, Rubino R, Inglese M, De Cata A. Behcet syndrome: from pathogenesis to novel therapies. Clin Exp Med. 2016;16(1):1–12. doi:10.1007/s10238-014-0328-z.
   PubMed Web of Science ®Google Scholar
• Gheita TA, Abd El-Latif EM, El-Gazzar II, et al.; on behalf of Egyptian College of Rheumatology – Behçet’s Disease Study Group (ECR-BDSG). Prevalence, gender-predominance and clinical presentation of Behçet’s disease in Egypt: preliminary findings from a multicenter nationwide study. Ann Rheum Dis. 2018;77(2):1762–1763.
   Google Scholar
• Leccese P, Alpsoy E. Behçet’s disease: an overview of etiopathogenesis. Front Immunol. 2019;10:1067. doi:10.3389/fimmu.2019.01067.
   PubMed Web of Science ®Google Scholar
• Van Kooten C, Banchereau J. CD40‐CD40 ligand. J Leukoc Biol. 2000;67(1):2–17. doi:10.1002/jlb.67.1.2.
   PubMed Web of Science ®Google Scholar
• Mousa TG, Omar HH, Emad R, et al. The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients. Clin Rheumatol. 2019;38(3):777–784. doi:10.1007/s10067-018-4349-y.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri S, Ef R, At L, et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet. 2008;40(10):1216–1223. doi:10.1038/ng.233.
   PubMed Web of Science ®Google Scholar
• Inal EE, Rüstemoğlu A, Inanır A, et al. Associations of rs4810485 and rs1883832 polymorphisms of CD40 gene with susceptibility and clinical findings of Behçet’s disease. Rheumatol Int. 2015;35(5):837–843. doi:10.1007/s00296-014-3171-3.
   PubMed Web of Science ®Google Scholar
• Jiang C, Ito M, Piening V, Bruck K, Roeder RG, Xiao H. TIP30 interacts with an estrogen receptor-interacting coactivator CIA and regulates C-Myc transcription. J Biol Chem. 2004;279(26):27781–27789. doi:10.1074/jbc.M401809200.
   PubMed Web of Science ®Google Scholar
• Yates AD, Achuthan P, Akanni W, et al. Ensembl 2020. Nucleic Acids Res. 2020;48(D1):D682- D688. doi:10.1093/nar/gkz966.
   PubMed Web of Science ®Google Scholar
• UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47(D1):D506- D515. doi:10.1093/nar/gky1049.
   PubMed Web of Science ®Google Scholar
• Gillespie MA, Gold ES, Ramsey SA, Podolsky I, Aderem A, Ranish JA. An LXR-NCOA5 gene regulatory complex directs inflammatory crosstalk-dependent repression of macrophage cholesterol efflux. Embo J. 2015;34(9):1244–1258. doi:10.15252/embj.201489819.
   PubMed Web of Science ®Google Scholar
• Bensinger SJ, Bradley MN, Joseph SB, et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell. 2008;134(1):97–111. doi:10.1016/j.cell.2008.04.052.
   PubMed Web of Science ®Google Scholar
• He P, Sun L, Zhu D, et al. Knock-down of endogenous bornavirus-like nucleoprotein 1 inhibits cell growth and induces apoptosis in human oligodendroglia cells. Int J Mol Sci. 2016;17(4):435. doi:10.3390/ijms17040435.
   PubMed Web of Science ®Google Scholar
• Liu X, Liu F, Gao S, et al. A single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulation. Cancer Lett. 2017;391:152–161. doi:10.1016/j.canlet.2017.01.028.
   PubMed Web of Science ®Google Scholar
• Böser A, Drexler HC, Reuter H, et al. SILAC proteomics of planarians identifies Ncoa5 as a conserved component of pluripotent stem. cells. 2013;Cell5(4:1142–1155.
   Google Scholar
• Jubb AW, Boyle S, Hume DA, Bickmore WA. Glucocorticoid receptor binding induces rapid and prolonged large-scale chromatin decompaction at multiple target Loci. Cell Rep. 2017;21(11):3022–3031. doi:10.1016/j.celrep.2017.11.053.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang BH, Gong JP. Genes and molecular mechanisms affecting the correlation between liver cancer and diabetes mellitus. Zhonghua Gan Zang Bing Za Zhi. 2018;26(9):718–720. doi:10.3760/cma.j.1007-3418.2018.09.020.
   PubMedGoogle Scholar
• Gao S, Li A, Liu F, et al. NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma. Cancer Cell. 2013;24(6):725–737. doi:10.1016/j.ccr.2013.11.005.
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhang T, Shi M, et al. Low expression of NCOA5 predicts poor prognosis in human cervical cancer and promotes proliferation, migration, and invasion of cervical cancer cell lines by regulating notch3 signaling pathway. J Cell Biochem. 2019;120(4):6237–6249. doi:10.1002/jcb.27911.
   PubMed Web of Science ®Google Scholar
• Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834):121–124. doi:10.1126/science.1140485.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wu J, Dong QR, Guo NZ. Association between expression of nuclear receptor co-activator 5 protein and prognosis in postoperative patients with osteosarcoma. Oncol Lett. 2018;15(2):1888–1892. doi:10.3892/ol.2017.7513.
   PubMed Web of Science ®Google Scholar
• Ye X, Huang D, Luo R. NCOA5 is correlated with progression and prognosis in luminal breast cancer. Biochem Biophys Res Commun. 2017;482(2):253–256. doi:10.1016/j.bbrc.2016.11.051.
   PubMed Web of Science ®Google Scholar
• Lewis JP, Palmer ND, Ellington JB, et al. Analysis of candidate genes on chromosome 20q12‐13.1 reveals evidence for BMI mediated association of PREX1 with type 2 diabetes in European Americans. Genomics. 2010;96(4):211‐ 219. doi:10.1016/j.ygeno.2010.07.006.
   PubMed Web of Science ®Google Scholar
• Vilariño-Güell C, Zimprich A, Martinelli-Boneschi F, et al. Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease. PloS Genet. 2019;15(6):e1008180. Erratum in: PloS Genet. 2020 Apr 9;16(4):e1008737. doi:10.1371/journal.pgen.1008180.
   PubMed Web of Science ®Google Scholar
• Zervou MI, Goulielmos GN, Castro-Giner F, Boumpas DT, Tosca AD, Krueger-Krasagakis S. A CD40 and an NCOA5 gene polymorphism confer susceptibility to psoriasis in a Southern European population: a case–control study. Hum Immunol. 2011;72(9):761–765. doi:10.1016/j.humimm.2011.05.014.
   PubMed Web of Science ®Google Scholar
• Den Dunnen JT, Dalgleish R, Maglott DR, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37(6):564–569. doi:10.1002/humu.22981.
   PubMed Web of Science ®Google Scholar
• Rustemoglu A, Inal EE, Inanir A, et al. Clinical significance of NCOA5 gene rs2903908 polymorphism in Behçet’s disease. Excli J. 2017;16:609–617. doi:10.17179/excli2017-189.
   PubMed Web of Science ®Google Scholar
• Villarreal-Martínez A, Gallardo-Blanco H, Cerda-Flores R, et al. Candidate gene polymorphisms and risk of psoriasis: a pilot study. Exp Ther Med. 2016;11(4):1217–1222. doi:10.3892/etm.2016.3066.
   PubMed Web of Science ®Google Scholar
• Davatchi F, Assaad-Khalil S, Calamia KT, et al. the international criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338–347. doi:10.1111/jdv.12107.
   PubMed Web of Science ®Google Scholar
• Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ. Behçet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatol. 1999;38(8):728–733. doi:10.1093/rheumatology/38.8.728.
   PubMed Web of Science ®Google Scholar
• Krause I, Molad Y, Weinberger A. Association of HLA-B5 with clinical expression and severity of Behcet’s disease in Israel. J Clin Rheumatol. 1999a;5(3):137–140. doi:10.1097/00124743-199906000-00005.
   PubMed Web of Science ®Google Scholar
• Maberley DA, Hollands H, Chuo J, et al. The prevalence of low vision and blindness in Canada. Eye (Lond). 2006;20(3):341–346. doi:10.1038/sj.eye.6701879.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C T method. Nat Protoc. 2008;3(6):1101–1108. doi:10.1038/nprot.2008.73.
   PubMed Web of Science ®Google Scholar
• Deng Y, Zhu W, Zhou X. Immune regulatory genes are major genetic factors to behcet disease: systematic review. Open Rheumatol J. 2018;12(1):70–85. doi:10.2174/1874312901812010070.
   PubMedGoogle Scholar
• Kim JH, Bachmann RA, Chen J. Interleukin-6 and insulin resistance. Vitam Horm. 2009;80:613–633.
   PubMed Web of Science ®Google Scholar
• Liu K, Zou C, Qin B. The association between nuclear receptors and ocular diseases. Oncotarget. 2017;8(16):27603–27615. doi:10.18632/oncotarget.15178.
   PubMedGoogle Scholar
• Velez G, Machlab DA, Tang PH, et al. Proteomic analysis of the human retina reveals region-specific susceptibilities to metabolic-and oxidative stress-related diseases. PloS One. 2018;13(2):e0193250. doi:10.1371/journal.pone.0193250.
   PubMed Web of Science ®Google Scholar
• Wishart DS, Knox C, Guo AC, et al. Drugbank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34:D668–672. doi:10.1093/nar/gkj067.
   PubMed Web of Science ®Google Scholar
• Wilk JB, Walter RE, Laramie JM, Gottlieb DJ, O’Connor GT. Framingham heart study genome-wide association: results for pulmonary function measures. BMC Med Genet. 2007;8(Suppl 1 (Suppl1)):S8. doi:10.1186/1471-2350-8-S1-S8.
   PubMedGoogle Scholar
• Kopanos C, Tsiolkas V, Kouris A, et al. VarSome: the human genomic variant search engine. Bioinformatics. 2019;35(11):1978–1980. doi:10.1093/bioinformatics/bty897.
   PubMed Web of Science ®Google Scholar
• Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40:D930–934. doi:10.1093/nar/gkr917.
   PubMed Web of Science ®Google Scholar
• Crunkhorn S. Autoimmune disease: aryl hydrocarbon receptor suppresses inflammation. Nat Rev Drug Discov. 2018;17(7):470. doi:10.1038/nrd.2018.107.
   Google Scholar
• Palizgir MT, Akhtari M, Mahmoudi M, et al. Macrophages from Behcet’s disease patients express decreased level of aryl hydrocarbon receptor (AHR) mRNA. Iran J Allergy Asthma Immunol. 2017;16:418–424.
   PubMed Web of Science ®Google Scholar
• Wang C, Ye Z, Kijlstra A, Zhou Y, Yang P. Decreased expression of the aryl hydrocarbon receptor in ocular Behcet’s disease. Mediators Inflamm. 2014;(2014):195094. doi:10.1155/2014/195094.
   PubMed Web of Science ®Google Scholar
• Di Meglio P, Duarte JH, Ahlfors H, et al. Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity. 2014;40(6):989–1001. doi:10.1016/j.immuni.2014.04.019.
   PubMed Web of Science ®Google Scholar
• Zhang F, Xu Y, Cao H, et al. Mapsnp: an R package to plot a genomic map for single nucleotide polymorphisms. PloS One. 2015;10(4):e0123609. doi:10.1371/journal.pone.0123609.
   PubMed Web of Science ®Google Scholar
• Machiela MJ, Chanock SJ. Ldlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31(21):3555–3557. doi:10.1093/bioinformatics/btv402.
   PubMed Web of Science ®Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The Protein Data Bank. Nucleic Acids Res. 2000;28(1):235–242. doi:10.1093/nar/28.1.235.
   PubMed Web of Science ®Google Scholar
• Kim S, Chen J, Cheng T, et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2019;47(D1):D1102–D1109. doi:10.1093/nar/gky1033.
   PubMed Web of Science ®Google Scholar
• BIOvIA DS. Discovery Studio Modeling Environment. San Diego: Dassault Systemes, Release; 2015:4.
   Google Scholar
• Auton A, Brooks LD, Durbin RM, et al.; 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.
   PubMed Web of Science ®Google Scholar